Table 3.
Results of univariate Cox regression analyses with OS in SCC and AC
| SCC (n=83) | ||
|---|---|---|
| O S | ||
| HR (95%CI) | p value | |
| SUVmax | 3.62 (0.93-23.76) | 0.06 |
| SUVmean | 1.91 (0.57-6.65) | 0.29 |
| MTV | 7.48 (1.71-27.28) | 0.01 |
| TLG | NA | < 0.01 |
| Size | 2.39(0.63-7.93) | 0.01 |
| Age | 1.39(0.40-6.39) | 0.62 |
| Lymph node(positive /negative) | 1.46 (0.42-4.82) | 0.54 |
| Paraaortic lymph node(positive /negative) | 1.56 (0.24-6.08) | 0.59 |
| FIGO(Ⅲ-ⅣA / I B-Ⅱ) | 3.62 (1.05-16.56) | 0.04 |
| Treatment(others / surgery) | 3.40 (1.02-13.13) | 0.05 |
| AC (n=35) | ||
| SUVmax | 1.10 (0.15-5.67) | 0.91 |
| SUVmean | 0.84 (0.15-4.56) | 0.84 |
| MTV | 23.37 (3.64-454.85) | < 0.01 |
| TLG | 15.41(2.46-296.17) | < 0.01 |
| Size | 11.15 (1.79-213.76) | < 0.01 |
| Age | 7.39 (1.17-140.41) | 0.03 |
| Lymph node(positive /negative) | 1.83 (0.34-9.97) | 0.46 |
| Paraaortic lymph node(positive / negative) | 2.28 (0.12-14.60) | 0.50 |
| FIGO (Ⅲ-ⅣA / I B-Ⅱ) | 8.14 (1.30-156.59) | 0.02 |
| Treatment (others/ surgery) | 24.02 (3.86-460.85) | <0.01 |